These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 11124630)

  • 1. Dosage of lamivudine in a haemodialysis patient.
    Izzedine H; Launay-Vacher V; Deray G
    Nephron; 2000 Dec; 86(4):553. PubMed ID: 11124630
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of efavirenz in a patient on maintenance haemodialysis.
    Izzedine H; Aymard G; Launay-Vacher V; Hamani A; Deray G
    AIDS; 2000 Mar; 14(5):618-9. PubMed ID: 10780727
    [No Abstract]   [Full Text] [Related]  

  • 3. Indinavir pharmacokinetics in haemodialysis-dependent end-stage renal failure.
    Guardiola JM; Mangues MA; Domingo P; Martínez E; Barrio JL
    AIDS; 1998 Jul; 12(11):1395. PubMed ID: 9708423
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetic of nevirapine in haemodialysis.
    Izzedine H; Launay-Vacher V; Aymard G; Legrand M; Deray G
    Nephrol Dial Transplant; 2001 Jan; 16(1):192-3. PubMed ID: 11209031
    [No Abstract]   [Full Text] [Related]  

  • 5. Population pharmacokinetics of lamivudine in human immunodeficiency virus-exposed and -infected infants.
    Tremoulet AH; Capparelli EV; Patel P; Acosta EP; Luzuriaga K; Bryson Y; Wara D; Zorrilla C; Holland D; Mirochnick M;
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4297-302. PubMed ID: 17893155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lamivudine treatment: realities and expectations].
    Crespo J; Pons-Romero F
    Gastroenterol Hepatol; 1997 Oct; 20(8):422-5. PubMed ID: 9410542
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical outcome of long-term lamivudine treated chronic HBV infected and HIV/HBV coinfected patients.
    Elefsiniotis IS; Paparizos V; Dourakis SP; Mpotsi C; Pantazis KD; Katsambas N
    J Clin Virol; 2005 May; 33(1):80-2. PubMed ID: 15797371
    [No Abstract]   [Full Text] [Related]  

  • 8. Dutrebis (lamivudine and raltegravir) for use in combination with other antiretroviral products for the treatment of HIV-1 infection.
    Casado JL; Bañón S
    Expert Rev Clin Pharmacol; 2015; 8(6):709-18. PubMed ID: 26517111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lamivudine-zidovudine combination treatment].
    Mörike EM
    Dtsch Med Wochenschr; 1996 Oct; 121(40):A8, A11. PubMed ID: 8925752
    [No Abstract]   [Full Text] [Related]  

  • 10. Response of HIV-associated thrombocytopenia to triple agent antiretroviral therapy.
    Walsh JC; Costello CE; Nelson MR
    AIDS; 1997 Mar; 11(3):399-400. PubMed ID: 9147442
    [No Abstract]   [Full Text] [Related]  

  • 11. Emtricitabine intolerance in treatment-experienced patients switched from lamivudine: a method of assessing toxicity.
    Pollock K; Stebbing J; Bower M; Gazzard B; Nelson M
    J Antimicrob Chemother; 2006 Jul; 58(1):227-8. PubMed ID: 16684800
    [No Abstract]   [Full Text] [Related]  

  • 12. A novel pharmacokinetic approach to predict virologic failure in HIV-1-infected paediatric patients.
    Bouazza N; Tréluyer JM; Msellati P; Van de Perre P; Diagbouga S; Nacro B; Hien H; Zoure E; Rouet F; Ouiminga A; Blanche S; Hirt D; Urien S
    AIDS; 2013 Mar; 27(5):761-8. PubMed ID: 23719348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abacavir plus lamivudine: a thymidine analogue-sparing NRTI backbone.
    Moyle GJ
    AIDS Read; 2003 Nov; 13(11):528, 533-5. PubMed ID: 14649622
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological basis for concentration-controlled therapy with zidovudine, lamivudine, and indinavir.
    Kakuda TN; Page LM; Anderson PL; Henry K; Schacker TW; Rhame FS; Acosta EP; Brundage RC; Fletcher CV
    Antimicrob Agents Chemother; 2001 Jan; 45(1):236-42. PubMed ID: 11120972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination antiretroviral therapy with tenofovir, emtricitabine or lamivudine, and nevirapine.
    Redfield RR; Morrow JS
    Clin Infect Dis; 2008 Oct; 47(7):984-5. PubMed ID: 18778234
    [No Abstract]   [Full Text] [Related]  

  • 16. [Human immunodeficiency virus and Chagas disease coinfection treated successfully with benznidazole and a raltegravir-based antiretroviral regimen: a case report].
    Rodríguez-Guardado A; Tuset M; Asensi V; Miró JM
    Med Clin (Barc); 2011 Sep; 137(6):278-9. PubMed ID: 20980024
    [No Abstract]   [Full Text] [Related]  

  • 17. [First HIV triple therapy with one tablet].
    Dtsch Med Wochenschr; 2000 Feb; 125(8):A22. PubMed ID: 10723466
    [No Abstract]   [Full Text] [Related]  

  • 18. Reflections: neurology and the humanities: reflections for October.
    Birbeck GL
    Neurology; 2009 Oct; 73(15):1245-6. PubMed ID: 19822877
    [No Abstract]   [Full Text] [Related]  

  • 19. Lamivudine for the treatment of HIV.
    Kumar PN; Patel P
    Expert Opin Drug Metab Toxicol; 2010 Jan; 6(1):105-14. PubMed ID: 20001611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of patients with initial early virologic failure after being treated with once-daily tenofovir/abacavir/lamivudine.
    Khanlou H; Farthing C
    AIDS Patient Care STDS; 2006 Sep; 20(9):604-5. PubMed ID: 16987045
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.